Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics

INTRODUCTION: Psoriasis has not been directly linked to a poor prognosis for COVID-19, yet immunomodulatory agents used for its management may lead to increased vulnerability to the dangerous complications of SARS-CoV-2 infection, as well as impair the effectiveness of the recently introduced vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Graceffa, Dario, Sperati, Francesca, Bonifati, Claudio, Spoletini, Gabriele, Lora, Viviana, Pimpinelli, Fulvia, Pontone, Martina, Pellini, Raul, Di Bella, Ornella, Morrone, Aldo, Cristaudo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485492/
https://www.ncbi.nlm.nih.gov/pubmed/36148445
http://dx.doi.org/10.3389/fmed.2022.961904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485492/
https://www.ncbi.nlm.nih.gov/pubmed/36148445
http://dx.doi.org/10.3389/fmed.2022.961904

Ejemplares similares